When does Kubota Pharmaceutical (4596.T) report earnings?

Kubota Pharmaceutical (4596.T) is scheduled to report results on **13 Feb 2026**. The earnings release will likely include updates on clinical timelines, expenses and cash position that directly affect 4596.T stock.

What key metrics should I watch in the 4596.T earnings report?

Focus on trial enrollment updates, guidance on R&D spend, cash balance per share (**JPY 25.11**) and operating cash flow. Those items will most strongly influence near-term 4596.T stock moves.

What is Meyka AI’s 12-month forecast for 4596.T stock?

Meyka AI's forecast model projects **JPY 98.52** as a 12-month target, implying about **-43.70%** versus the current **JPY 175.00**. Forecasts are model-based projections and not guarantees.

Is 4596.T stock high risk or high reward?

4596.T stock is high-risk/high-reward due to binary clinical catalysts. Strong trial news could push the stock toward the year high, while negative outcomes could sharply lower the price. Position size accordingly.

JP Stocks

4596.T Kubota Pharmaceutical Holdings (JPX) after hours: 11 Feb 2026 earnings preview

ByDanny Kontos February 11, 2026February 11, 2026

The stock to watch before Kubota Pharmaceutical Holdings Co., Ltd.’s earnings is 4596.T stock, trading on JPX at JPY 175.00 after hours on 11 Feb 2026. Volume surged to 36,299,100 shares today versus an average of 4,877,850, signalling heavy interest ahead of the company’s earnings announcement scheduled for 13 Feb 2026. Investors will focus on trial updates for emixustat and operating cash flow, where recent metrics show EPS -19.46 and a negative PE ratio. We highlight the key catalysts and model-driven price scenarios below